S&S Healthcare Holding Ltd. (4198.TWO) Stock
S&S Healthcare Holding Ltd. focuses on the research and development, manufacture, and sales of medical imaging devices in Taiwan, the United States, Switzerland, and internationally.
Valuation
Financials & Margins
Valuation & Return Ratios
About S&S Healthcare Holding Ltd.
S&S Healthcare Holding Ltd. focuses on the research and development, manufacture, and sales of medical imaging devices in Taiwan, the United States, Switzerland, and internationally. It develops digital diagnostic X-ray systems; and researches, develops, and produces bone densitometry and body composition assessment products. The company was formerly known as Swissray Global Healthcare Holding Ltd. and changed its name to S&S Healthcare Holding Ltd. in August 2020. S&S Healthcare Holding Ltd. was founded in 1988 and is headquartered in Taipei, Taiwan.
S&S Healthcare Holding Ltd. is led by CEO Tien-Ying Lee, employs 200 people, headquartered in Taipei, TW, publicly traded since 2013.
S&S Healthcare Holding Ltd. (4198.TWO) stock trades at $47.70 with a market capitalization of $1.15B. The stock is valued at a negative price-to-earnings (P/E) ratio of -28.39, reflecting a net loss over the last twelve months, price-to-book of 5.64, price-to-sales of 6.67. Over the past 52 weeks the stock has ranged between $29.95 and $52.50, and currently trades 9.1% below its 52-week high.
On profitability, S&S Healthcare Holding Ltd. generates a return on equity (ROE) of -15.69% (negative, reflecting a net loss), an operating margin of -44.24%, a net profit margin of -23.47%.
Official website: www.swissray.com
S&S Healthcare Holding Ltd. (4198.TWO) — frequently asked questions
What is S&S Healthcare Holding Ltd. (4198.TWO) stock price today?
S&S Healthcare Holding Ltd. (4198.TWO) is currently trading at $47.70, down 3.05% today.
What is 4198.TWO P/E ratio?
S&S Healthcare Holding Ltd.'s P/E ratio is -28.39. A negative P/E means the company reported a net loss over the last twelve months, so P/E is not a meaningful valuation measure for it right now.
What is 4198.TWO return on equity (ROE)?
S&S Healthcare Holding Ltd.'s return on equity (ROE) is -15.69%. ROE measures net income relative to shareholders' equity. A negative ROE means the company reported a net loss over the period.
What is S&S Healthcare Holding Ltd.'s market cap?
S&S Healthcare Holding Ltd. has a market capitalization of $1.15B.
Does 4198.TWO pay a dividend?
S&S Healthcare Holding Ltd. is not currently showing a dividend yield in our data, which means no recent cash dividend was recorded for it.
How much debt does 4198.TWO carry?
S&S Healthcare Holding Ltd. has a debt-to-equity ratio of 0.11. That compares total borrowings with shareholders' equity: a figure under 1 means equity exceeds debt.
What is 4198.TWO's profit margin?
S&S Healthcare Holding Ltd. reports a net profit margin of -23.47% — the share of revenue left after every cost, including tax and interest.
What sector is 4198.TWO in?
S&S Healthcare Holding Ltd. is classified under Healthcare, in the Medical Devices industry. Ratios are most informative compared with other companies in the same industry rather than across the whole market.
Which exchange is 4198.TWO listed on?
S&S Healthcare Holding Ltd. trades on TWO under the ticker 4198.TWO.
What is 4198.TWO's 52-week range?
Over the last year S&S Healthcare Holding Ltd. has traded between $29.95 and $52.50.
Related Healthcare Stocks
Popular Stocks
Screens 4198.TWO currently matches
On the figures above, S&S Healthcare Holding Ltd. passes the filters for 6 of our ready-made screens, among them Low Debt Stocks, Small Cap Stocks, Stocks Under $100. Appearing on a screen means the numbers meet its filters today and nothing more; the list is rebuilt whenever the data changes.
Related stock screens
Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.